ArticleNature communications2022

STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer.

Qiwei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.